Industry Developments

BMI View: A worsening economic outlook, combined with comments from the Czech health minister Leos Heger in mid-November 2011, indicate that public funding for healthcare services will... 2011-11-17

BMI View: Moldova's small market size and its status as one of the poorest countries in Europe limit its attractiveness as a destination for investment. However, it is the most liberal... 2011-11-16

BMI View: The defeat of a bill that would have led to a complete ban on the advertising over-the-counter (OTC) medicines in Ukraine will be welcomed by drug makers operating in the... 2011-11-15

BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical market has performed strongly in first nine months of 2011, which has led to upward revisions in our... 2011-11-14

BMI View: Early-stage discussions to decide on a new method for the Russian authorities to regulate the compensated price of medicines creates new risks for drugmakers operating in... 2011-11-08

BMI View: As the privatisation of Poland's state-owned drugmakers and distributors draws to an end, it seems that domestic firms have been the main winners in the three-year process.... 2011-11-07

BMI View: While the value of the fine administered to Sofia-based drugmaker Adipharm for imitating one of Bayer's product is quite small, the decision by Bulgaria's Commission on the... 2011-11-04

BMI View: Governments across Central Europe have been quick to introduce drug policy reforms that aim to reduce pharmaceutical expenditure and shift the financial burden on to patients... 2011-11-02

BMI View: Russia looks set to receive the green light for WTO membership during a conference in Geneva in mid-December, completing a long and drawn-out accession process that has lasted... 2011-11-02

BMI View: Driven by government investment in the healthcare sector, Turkey's medical device market remains one of the most attractive targets for manufacturers in emerging Europe. While... 2011-10-26